| 0 |
IMMUNE-MEDIATED PANCYTOPENIA |
37 |
0.7551 |
| 1 |
IMMUNE-MEDIATED HYPOTHYROIDISM |
701 |
0.6215 |
| 2 |
IMMUNE-MEDIATED RENAL DISORDER |
257 |
0.6208 |
| 3 |
IMMUNE-MEDIATED HYPERTHYROIDISM |
156 |
0.6142 |
| 4 |
IMMUNE-MEDIATED GASTRITIS |
115 |
0.5990 |
| 5 |
IMMUNE-MEDIATED ADRENAL INSUFFICIENCY |
477 |
0.5985 |
| 6 |
IMMUNE-MEDIATED ADVERSE REACTION |
893 |
0.5814 |
| 7 |
IMMUNE-MEDIATED NEUROLOGICAL DISORDER |
48 |
0.5517 |
| 8 |
IMMUNE-MEDIATED HEPATIC DISORDER |
1047 |
0.5364 |
| 9 |
IMMUNE-MEDIATED THYROIDITIS |
263 |
0.5324 |
| 10 |
IMMUNE-MEDIATED NEUROPATHY |
80 |
0.5161 |
| 11 |
IMMUNE-MEDIATED OESOPHAGITIS |
37 |
0.5139 |
| 12 |
IMMUNE-MEDIATED ENDOCRINOPATHY |
77 |
0.5133 |
| 13 |
IMMUNE-MEDIATED PNEUMONITIS |
117 |
0.5000 |
| 14 |
IMMUNE-MEDIATED PANCREATITIS |
189 |
0.4961 |
| 15 |
IMMUNE-MEDIATED ARTHRITIS |
187 |
0.4908 |
| 16 |
TUMOUR HYPERPROGRESSION |
121 |
0.4879 |
| 17 |
IMMUNE-MEDIATED MYOCARDITIS |
779 |
0.4821 |
| 18 |
IMMUNE-MEDIATED DERMATITIS |
478 |
0.4742 |
| 19 |
IMMUNE-MEDIATED MYASTHENIA GRAVIS |
153 |
0.4708 |
| 20 |
TRANSITIONAL CELL CARCINOMA METASTATIC |
55 |
0.4701 |
| 21 |
MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME |
104 |
0.4561 |
| 22 |
TUMOUR PSEUDOPROGRESSION |
475 |
0.4338 |
| 23 |
IMMUNE-MEDIATED HYPOPHYSITIS |
191 |
0.4235 |
| 24 |
IMMUNE-MEDIATED CHOLANGITIS |
150 |
0.4178 |
| 25 |
IMMUNE-MEDIATED ENCEPHALITIS |
217 |
0.4102 |
| 26 |
IMMUNE-MEDIATED NEPHRITIS |
190 |
0.4051 |
| 27 |
IMMUNE-MEDIATED CYSTITIS |
46 |
0.4000 |
| 28 |
ADRENOCORTICOTROPIC HORMONE DEFICIENCY |
343 |
0.3907 |
| 29 |
IMMUNE-MEDIATED LUNG DISEASE |
686 |
0.3759 |
| 30 |
MALIGNANT NEOPLASM OLIGOPROGRESSION |
73 |
0.3668 |
| 31 |
IMMUNE-MEDIATED HEPATITIS |
728 |
0.3562 |
| 32 |
AUTOIMMUNE LUNG DISEASE |
42 |
0.3559 |
| 33 |
AUTOIMMUNE HYPOTHYROIDISM |
84 |
0.3529 |
| 34 |
IMMUNOTOXICITY |
39 |
0.3421 |
| 35 |
ADRENALITIS |
36 |
0.3364 |
| 36 |
SILENT THYROIDITIS |
47 |
0.3264 |
| 37 |
IMMUNE-MEDIATED ENTEROCOLITIS |
1153 |
0.3132 |
| 38 |
PSEUDOCELLULITIS |
61 |
0.2850 |
| 39 |
IMMUNE-MEDIATED UVEITIS |
51 |
0.2787 |
| 40 |
UROGENITAL FISTULA |
66 |
0.2785 |
| 41 |
GLUCOCORTICOID DEFICIENCY |
112 |
0.2648 |
| 42 |
AUTOIMMUNE MYOCARDITIS |
54 |
0.2466 |
| 43 |
AUTOIMMUNE ARTHRITIS |
38 |
0.2420 |
| 44 |
AUTOIMMUNE COLITIS |
156 |
0.2419 |
| 45 |
HYPOPHYSITIS |
484 |
0.2404 |
| 46 |
AUTOIMMUNE NEPHRITIS |
52 |
0.2364 |
| 47 |
CERVIX CARCINOMA RECURRENT |
42 |
0.2360 |
| 48 |
KL-6 INCREASED |
51 |
0.2257 |
| 49 |
TUMOUR ASSOCIATED FEVER |
85 |
0.2078 |
| 50 |
THROMBOPHLEBITIS MIGRANS |
68 |
0.2000 |
| 51 |
BLOOD CORTICOTROPHIN DECREASED |
95 |
0.1947 |
| 52 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
241 |
0.1934 |
| 53 |
THYROIDITIS |
580 |
0.1929 |
| 54 |
RADIOTHERAPY |
353 |
0.1844 |
| 55 |
PRIMARY ADRENAL INSUFFICIENCY |
54 |
0.1770 |
| 56 |
MYASTHENIC SYNDROME |
126 |
0.1628 |
| 57 |
SARCOID-LIKE REACTION |
42 |
0.1628 |
| 58 |
LICHENOID KERATOSIS |
372 |
0.1627 |
| 59 |
FULMINANT TYPE 1 DIABETES MELLITUS |
153 |
0.1484 |
| 60 |
CORTISOL DECREASED |
169 |
0.1479 |
| 61 |
IMMUNE-MEDIATED MYOSITIS |
400 |
0.1450 |
| 62 |
BLOOD CORTICOTROPHIN INCREASED |
40 |
0.1384 |
| 63 |
EOSINOPHILIC FASCIITIS |
48 |
0.1383 |
| 64 |
NEPHRITIS |
462 |
0.1382 |
| 65 |
LYMPHOCYTIC HYPOPHYSITIS |
38 |
0.1377 |
| 66 |
ADRENAL INSUFFICIENCY |
1670 |
0.1375 |
| 67 |
MELANOMA RECURRENT |
56 |
0.1330 |
| 68 |
HYPOPITUITARISM |
229 |
0.1315 |
| 69 |
HYPOTHALAMO-PITUITARY DISORDER |
190 |
0.1304 |
| 70 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
194 |
0.1284 |
| 71 |
AUTOIMMUNE PANCREATITIS |
63 |
0.1245 |
| 72 |
THERAPY PARTIAL RESPONDER |
1914 |
0.1226 |
| 73 |
MALIGNANT NEOPLASM PROGRESSION |
12384 |
0.1208 |
| 74 |
TYPE 1 DIABETES MELLITUS |
727 |
0.1206 |
| 75 |
MYOCARDITIS |
1318 |
0.1149 |
| 76 |
VASCULAR ACCESS COMPLICATION |
84 |
0.1037 |
| 77 |
ADRENAL DISORDER |
192 |
0.0999 |
| 78 |
VITILIGO |
224 |
0.0954 |
| 79 |
HYPOTHYROIDISM |
3041 |
0.0951 |
| 80 |
ENCEPHALITIS AUTOIMMUNE |
116 |
0.0882 |
| 81 |
CHOLANGITIS SCLEROSING |
176 |
0.0856 |
| 82 |
RADIATION NECROSIS |
49 |
0.0855 |
| 83 |
PARANEOPLASTIC SYNDROME |
57 |
0.0843 |
| 84 |
PNEUMONITIS |
2271 |
0.0833 |
| 85 |
MYOSITIS |
711 |
0.0792 |
| 86 |
CYTOKINE STORM |
54 |
0.0788 |
| 87 |
LYMPHANGIOSIS CARCINOMATOSA |
79 |
0.0758 |
| 88 |
RADIATION PNEUMONITIS |
162 |
0.0756 |
| 89 |
TUMOUR NECROSIS |
78 |
0.0738 |
| 90 |
CHOLANGITIS |
455 |
0.0733 |
| 91 |
THYROID HORMONES DECREASED |
58 |
0.0725 |
| 92 |
LYMPHADENECTOMY |
70 |
0.0717 |
| 93 |
SKIN TOXICITY |
403 |
0.0712 |
| 94 |
FEMALE GENITAL TRACT FISTULA |
121 |
0.0708 |
| 95 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
137 |
0.0701 |
| 96 |
HEPATIC CYTOLYSIS |
893 |
0.0700 |
| 97 |
SMALL INTESTINAL PERFORATION |
129 |
0.0687 |
| 98 |
MALIGNANT PLEURAL EFFUSION |
116 |
0.0687 |
| 99 |
MYASTHENIA GRAVIS |
549 |
0.0679 |
| 100 |
THYROID HORMONES INCREASED |
68 |
0.0647 |
| 101 |
HYPERTHYROIDISM |
928 |
0.0640 |
| 102 |
DUODENAL PERFORATION |
62 |
0.0631 |
| 103 |
FEBRILE BONE MARROW APLASIA |
261 |
0.0614 |
| 104 |
CANCER PAIN |
153 |
0.0598 |
| 105 |
METASTATIC MALIGNANT MELANOMA |
137 |
0.0596 |
| 106 |
PULMONARY TOXICITY |
418 |
0.0590 |
| 107 |
SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS |
105 |
0.0590 |
| 108 |
MALIGNANT ASCITES |
45 |
0.0587 |
| 109 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
439 |
0.0584 |
| 110 |
POLYMYALGIA RHEUMATICA |
184 |
0.0579 |
| 111 |
ENCEPHALITIS |
395 |
0.0570 |
| 112 |
PROTEINURIA |
1072 |
0.0563 |
| 113 |
TUBULOINTERSTITIAL NEPHRITIS |
1055 |
0.0562 |
| 114 |
ENDOCRINE DISORDER |
72 |
0.0561 |
| 115 |
INTERSTITIAL LUNG DISEASE |
2630 |
0.0543 |
| 116 |
AUTOIMMUNE HEPATITIS |
376 |
0.0540 |
| 117 |
AORTITIS |
37 |
0.0539 |
| 118 |
COLITIS |
2021 |
0.0533 |
| 119 |
IMMUNE THROMBOCYTOPENIA |
244 |
0.0532 |
| 120 |
BLOOD LACTATE DEHYDROGENASE ABNORMAL |
36 |
0.0531 |
| 121 |
PEMPHIGOID |
392 |
0.0519 |
| 122 |
TUMOUR HAEMORRHAGE |
147 |
0.0515 |
| 123 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1197 |
0.0513 |
| 124 |
CANCER SURGERY |
48 |
0.0501 |
| 125 |
HYPERSENSITIVITY PNEUMONITIS |
57 |
0.0500 |
| 126 |
GASTROINTESTINAL PERFORATION |
204 |
0.0490 |
| 127 |
ENTEROCOLITIS |
276 |
0.0478 |
| 128 |
LICHEN PLANUS |
110 |
0.0474 |
| 129 |
TROPONIN INCREASED |
357 |
0.0469 |
| 130 |
MIXED LIVER INJURY |
140 |
0.0465 |
| 131 |
THYROTOXIC CRISIS |
51 |
0.0448 |
| 132 |
PULMONARY SARCOIDOSIS |
50 |
0.0445 |
| 133 |
TROPONIN I INCREASED |
74 |
0.0444 |
| 134 |
LUNG OPACITY |
117 |
0.0444 |
| 135 |
HEPATITIS |
1131 |
0.0442 |
| 136 |
MYOCARDIAL INJURY |
49 |
0.0436 |
| 137 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
396 |
0.0430 |
| 138 |
GUILLAIN-BARRE SYNDROME |
207 |
0.0428 |
| 139 |
HYPERTRANSAMINASAEMIA |
291 |
0.0418 |
| 140 |
THYROID DISORDER |
634 |
0.0411 |
| 141 |
TOXIC EPIDERMAL NECROLYSIS |
621 |
0.0409 |
| 142 |
BLOOD THYROID STIMULATING HORMONE ABNORMAL |
74 |
0.0401 |
| 143 |
AMYLASE INCREASED |
145 |
0.0393 |
| 144 |
AUTOIMMUNE THYROIDITIS |
147 |
0.0388 |
| 145 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
59 |
0.0387 |
| 146 |
TROPONIN T INCREASED |
49 |
0.0386 |
| 147 |
ACQUIRED GENE MUTATION |
50 |
0.0381 |
| 148 |
RENAL TUBULAR INJURY |
46 |
0.0379 |
| 149 |
HEPATIC FUNCTION ABNORMAL |
1400 |
0.0375 |
| 150 |
TUMOUR PAIN |
49 |
0.0372 |
| 151 |
ORGANISING PNEUMONIA |
184 |
0.0371 |
| 152 |
NEPHRECTOMY |
55 |
0.0370 |
| 153 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
52 |
0.0370 |
| 154 |
PRERENAL FAILURE |
52 |
0.0369 |
| 155 |
VANISHING BILE DUCT SYNDROME |
41 |
0.0368 |
| 156 |
BICYTOPENIA |
71 |
0.0362 |
| 157 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
123 |
0.0358 |
| 158 |
RENAL TUBULAR NECROSIS |
350 |
0.0356 |
| 159 |
DERMATITIS PSORIASIFORM |
72 |
0.0352 |
| 160 |
INFECTIOUS PLEURAL EFFUSION |
53 |
0.0348 |
| 161 |
BILIARY OBSTRUCTION |
45 |
0.0347 |
| 162 |
DERMATITIS BULLOUS |
246 |
0.0339 |
| 163 |
LYMPHADENOPATHY MEDIASTINAL |
65 |
0.0339 |
| 164 |
DUODENITIS |
104 |
0.0339 |
| 165 |
PHYSICAL DECONDITIONING |
87 |
0.0338 |
| 166 |
MASTECTOMY |
59 |
0.0337 |
| 167 |
GALLBLADDER ENLARGEMENT |
36 |
0.0334 |
| 168 |
CAPILLARY LEAK SYNDROME |
68 |
0.0329 |
| 169 |
MENINGITIS ASEPTIC |
146 |
0.0325 |
| 170 |
SIALOADENITIS |
44 |
0.0323 |
| 171 |
GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE |
36 |
0.0321 |
| 172 |
CARCINOEMBRYONIC ANTIGEN INCREASED |
62 |
0.0320 |
| 173 |
RECURRENT CANCER |
130 |
0.0318 |
| 174 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
144 |
0.0317 |
| 175 |
PROCALCITONIN INCREASED |
37 |
0.0315 |
| 176 |
MYELOSUPPRESSION |
1120 |
0.0311 |
| 177 |
MYELITIS TRANSVERSE |
43 |
0.0305 |
| 178 |
HEPATOTOXICITY |
672 |
0.0302 |
| 179 |
PANCREATIC FAILURE |
53 |
0.0300 |
| 180 |
OXYGEN THERAPY |
49 |
0.0298 |
| 181 |
ERYTHEMA MULTIFORME |
277 |
0.0297 |
| 182 |
PNEUMONIA BACTERIAL |
270 |
0.0294 |
| 183 |
ENTERITIS |
188 |
0.0293 |
| 184 |
DRUG ERUPTION |
515 |
0.0290 |
| 185 |
POLYARTHRITIS |
152 |
0.0288 |
| 186 |
OPHTHALMOPLEGIA |
45 |
0.0285 |
| 187 |
LARGE INTESTINE PERFORATION |
198 |
0.0285 |
| 188 |
PERIPHERAL MOTOR NEUROPATHY |
39 |
0.0278 |
| 189 |
CARDIAC TAMPONADE |
132 |
0.0277 |
| 190 |
METASTASES TO MENINGES |
63 |
0.0277 |
| 191 |
CARDIAC DYSFUNCTION |
102 |
0.0274 |
| 192 |
LUNG ADENOCARCINOMA |
82 |
0.0272 |
| 193 |
RASH MACULO-PAPULAR |
605 |
0.0272 |
| 194 |
CHOLECYSTITIS |
319 |
0.0268 |
| 195 |
ALANINE AMINOTRANSFERASE ABNORMAL |
56 |
0.0265 |
| 196 |
CENTRAL VENOUS CATHETERISATION |
80 |
0.0265 |
| 197 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
38 |
0.0264 |
| 198 |
INTESTINAL PERFORATION |
295 |
0.0263 |
| 199 |
CYTOKINE RELEASE SYNDROME |
526 |
0.0262 |
| 200 |
MUCOSAL INFLAMMATION |
676 |
0.0258 |
| 201 |
MYASTHENIA GRAVIS CRISIS |
38 |
0.0256 |
| 202 |
HEPATITIS CHOLESTATIC |
154 |
0.0255 |
| 203 |
GASTROINTESTINAL TOXICITY |
122 |
0.0254 |
| 204 |
EXTREMITY NECROSIS |
44 |
0.0252 |
| 205 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
252 |
0.0251 |
| 206 |
FEBRILE NEUTROPENIA |
1661 |
0.0250 |
| 207 |
PANCYTOPENIA |
1399 |
0.0250 |
| 208 |
DERMATOMYOSITIS |
63 |
0.0248 |
| 209 |
THYROID FUNCTION TEST ABNORMAL |
103 |
0.0248 |
| 210 |
STEVENS-JOHNSON SYNDROME |
543 |
0.0244 |
| 211 |
CHRONIC GASTRITIS |
55 |
0.0243 |
| 212 |
CHOLESTATIC LIVER INJURY |
54 |
0.0242 |
| 213 |
HEPATITIS TOXIC |
63 |
0.0242 |
| 214 |
GASTRITIS HAEMORRHAGIC |
36 |
0.0241 |
| 215 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
229 |
0.0240 |
| 216 |
RHEUMATIC DISORDER |
46 |
0.0238 |
| 217 |
CELL DEATH |
47 |
0.0237 |
| 218 |
HAEMATOTOXICITY |
224 |
0.0235 |
| 219 |
MENINGITIS |
157 |
0.0235 |
| 220 |
NEUROPATHY PERIPHERAL |
2221 |
0.0233 |
| 221 |
NEUTROPHIL COUNT DECREASED |
938 |
0.0230 |
| 222 |
LIVER ABSCESS |
74 |
0.0228 |
| 223 |
NON-SMALL CELL LUNG CANCER |
109 |
0.0227 |
| 224 |
RENAL TUBULAR DISORDER |
64 |
0.0227 |
| 225 |
TASTE DISORDER |
461 |
0.0227 |
| 226 |
RENAL IMPAIRMENT |
1879 |
0.0223 |
| 227 |
MYOCARDIAL NECROSIS MARKER INCREASED |
37 |
0.0221 |
| 228 |
POLYMYOSITIS |
39 |
0.0220 |
| 229 |
GASTRIC PERFORATION |
60 |
0.0220 |
| 230 |
ATRIOVENTRICULAR BLOCK COMPLETE |
144 |
0.0215 |
| 231 |
NEPHROPATHY TOXIC |
241 |
0.0214 |
| 232 |
LUNG ABSCESS |
45 |
0.0214 |
| 233 |
HEPATITIS FULMINANT |
63 |
0.0212 |
| 234 |
PERIPHERAL SENSORY NEUROPATHY |
124 |
0.0212 |
| 235 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
65 |
0.0211 |
| 236 |
CACHEXIA |
108 |
0.0210 |
| 237 |
COLITIS MICROSCOPIC |
99 |
0.0209 |
| 238 |
NEUTROPHIL COUNT ABNORMAL |
59 |
0.0209 |
| 239 |
SKIN DISORDER |
695 |
0.0208 |
| 240 |
DIABETIC KETOACIDOSIS |
500 |
0.0208 |
| 241 |
CARDIOTOXICITY |
185 |
0.0207 |
| 242 |
CHOLESTASIS |
395 |
0.0206 |
| 243 |
IMMUNE THROMBOCYTOPENIC PURPURA |
58 |
0.0205 |
| 244 |
CHOLECYSTITIS ACUTE |
116 |
0.0205 |
| 245 |
NEOPLASM PROGRESSION |
711 |
0.0204 |
| 246 |
STOMATITIS |
1225 |
0.0202 |
| 247 |
PNEUMOTHORAX |
320 |
0.0202 |
| 248 |
HYDRONEPHROSIS |
150 |
0.0200 |
| 249 |
EYELID PTOSIS |
203 |
0.0200 |
| 250 |
NEPHROTIC SYNDROME |
136 |
0.0198 |
| 251 |
LUNG CONSOLIDATION |
55 |
0.0196 |
| 252 |
PYELONEPHRITIS |
170 |
0.0196 |
| 253 |
SKIN EROSION |
63 |
0.0195 |
| 254 |
APLASIA PURE RED CELL |
67 |
0.0195 |
| 255 |
DISSEMINATED INTRAVASCULAR COAGULATION |
271 |
0.0192 |
| 256 |
SARCOIDOSIS |
91 |
0.0191 |
| 257 |
RASH MORBILLIFORM |
53 |
0.0191 |
| 258 |
TUMOUR LYSIS SYNDROME |
166 |
0.0188 |
| 259 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
243 |
0.0188 |
| 260 |
BLOOD CHLORIDE DECREASED |
48 |
0.0186 |
| 261 |
ILEUS |
231 |
0.0186 |
| 262 |
SMALL INTESTINAL HAEMORRHAGE |
37 |
0.0184 |
| 263 |
ADENOCARCINOMA |
41 |
0.0183 |
| 264 |
PROTEIN URINE PRESENT |
91 |
0.0182 |
| 265 |
PNEUMATOSIS INTESTINALIS |
52 |
0.0182 |
| 266 |
HOSPICE CARE |
180 |
0.0182 |
| 267 |
CYTOPENIA |
222 |
0.0181 |
| 268 |
KERATITIS |
55 |
0.0181 |
| 269 |
STRESS CARDIOMYOPATHY |
105 |
0.0180 |
| 270 |
NEUTROPENIA |
2450 |
0.0180 |
| 271 |
BLOOD CREATININE ABNORMAL |
62 |
0.0179 |
| 272 |
AORTIC ARTERIOSCLEROSIS |
46 |
0.0179 |
| 273 |
DIASTOLIC DYSFUNCTION |
55 |
0.0178 |
| 274 |
PERICARDIAL EFFUSION |
411 |
0.0178 |
| 275 |
CARDIAC FAILURE ACUTE |
117 |
0.0175 |
| 276 |
PULSE ABNORMAL |
42 |
0.0174 |
| 277 |
HYPOALBUMINAEMIA |
135 |
0.0173 |
| 278 |
DERMATITIS EXFOLIATIVE GENERALISED |
60 |
0.0172 |
| 279 |
ASCITES |
503 |
0.0171 |
| 280 |
RASH VESICULAR |
82 |
0.0169 |
| 281 |
HENOCH-SCHONLEIN PURPURA |
37 |
0.0169 |
| 282 |
THROMBOCYTOPENIA |
1884 |
0.0168 |
| 283 |
PLEURAL EFFUSION |
1021 |
0.0168 |
| 284 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
64 |
0.0167 |
| 285 |
SYSTEMIC CANDIDA |
42 |
0.0167 |
| 286 |
ACUTE KIDNEY INJURY |
2550 |
0.0166 |
| 287 |
HAEMOGLOBIN ABNORMAL |
107 |
0.0166 |
| 288 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
469 |
0.0165 |
| 289 |
PLATELET COUNT DECREASED |
1757 |
0.0165 |
| 290 |
LIPASE INCREASED |
126 |
0.0164 |
| 291 |
DUODENAL ULCER |
116 |
0.0164 |
| 292 |
DYSPHONIA |
955 |
0.0163 |
| 293 |
TOXIC SKIN ERUPTION |
163 |
0.0162 |
| 294 |
CARBOHYDRATE ANTIGEN 125 INCREASED |
55 |
0.0161 |
| 295 |
METASTASES TO PERITONEUM |
40 |
0.0158 |
| 296 |
DIABETES INSIPIDUS |
38 |
0.0158 |
| 297 |
HYPERTENSION |
3339 |
0.0157 |
| 298 |
OESOPHAGITIS |
172 |
0.0157 |
| 299 |
SUSPECTED OFF LABEL USE |
71 |
0.0157 |
| 300 |
BREAST CANCER RECURRENT |
49 |
0.0155 |
| 301 |
CARDIOMYOPATHY |
229 |
0.0155 |
| 302 |
SEPTIC SHOCK |
670 |
0.0154 |
| 303 |
BLOOD POTASSIUM ABNORMAL |
41 |
0.0154 |
| 304 |
CEREBRAL INFARCTION |
372 |
0.0152 |
| 305 |
HYPERPYREXIA |
64 |
0.0151 |
| 306 |
CHEMOTHERAPY |
57 |
0.0151 |
| 307 |
NEOPLASM RECURRENCE |
51 |
0.0150 |
| 308 |
PERFORMANCE STATUS DECREASED |
70 |
0.0150 |
| 309 |
LIVER DISORDER |
665 |
0.0150 |
| 310 |
PULMONARY MASS |
220 |
0.0148 |
| 311 |
C-REACTIVE PROTEIN INCREASED |
536 |
0.0147 |
| 312 |
HYPOMAGNESAEMIA |
205 |
0.0147 |
| 313 |
GLOMERULONEPHRITIS |
36 |
0.0147 |
| 314 |
ADVERSE EVENT |
1353 |
0.0147 |
| 315 |
ASPARTATE AMINOTRANSFERASE INCREASED |
778 |
0.0146 |
| 316 |
DECREASED APPETITE |
3399 |
0.0146 |
| 317 |
DRUG-INDUCED LIVER INJURY |
459 |
0.0146 |
| 318 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
150 |
0.0146 |
| 319 |
PROTEIN TOTAL DECREASED |
55 |
0.0146 |
| 320 |
TRANSAMINASES INCREASED |
323 |
0.0145 |
| 321 |
PRODUCT USE IN UNAPPROVED INDICATION |
3594 |
0.0145 |
| 322 |
INFLAMMATORY MARKER INCREASED |
71 |
0.0143 |
| 323 |
IRIDOCYCLITIS |
45 |
0.0142 |
| 324 |
MYOPATHY |
123 |
0.0142 |
| 325 |
HEPATOCELLULAR INJURY |
200 |
0.0141 |
| 326 |
LEUKOPENIA |
702 |
0.0140 |
| 327 |
POLYNEUROPATHY |
168 |
0.0140 |
| 328 |
KETOACIDOSIS |
105 |
0.0140 |
| 329 |
HEPATITIS ACUTE |
91 |
0.0140 |
| 330 |
BLOOD ALBUMIN DECREASED |
111 |
0.0140 |
| 331 |
PRODUCT USE ISSUE |
2622 |
0.0139 |
| 332 |
DERMATITIS |
292 |
0.0139 |
| 333 |
EJECTION FRACTION DECREASED |
216 |
0.0139 |
| 334 |
ALANINE AMINOTRANSFERASE INCREASED |
853 |
0.0139 |
| 335 |
AGRANULOCYTOSIS |
258 |
0.0139 |
| 336 |
JAUNDICE CHOLESTATIC |
49 |
0.0139 |
| 337 |
EMBOLISM VENOUS |
42 |
0.0138 |
| 338 |
HYPONATRAEMIA |
779 |
0.0138 |
| 339 |
HYPERCALCAEMIA |
170 |
0.0138 |
| 340 |
GASTROINTESTINAL NECROSIS |
40 |
0.0137 |
| 341 |
ATELECTASIS |
132 |
0.0136 |
| 342 |
SKIN REACTION |
192 |
0.0136 |
| 343 |
HAEMOLYTIC ANAEMIA |
121 |
0.0135 |
| 344 |
METASTASES TO LUNG |
156 |
0.0135 |
| 345 |
PNEUMONIA ASPIRATION |
337 |
0.0135 |
| 346 |
SCLERODERMA |
49 |
0.0135 |
| 347 |
BLOOD MAGNESIUM DECREASED |
116 |
0.0134 |
| 348 |
AUTOIMMUNE DISORDER |
130 |
0.0133 |
| 349 |
PAPILLOEDEMA |
60 |
0.0133 |
| 350 |
GLOSSITIS |
47 |
0.0132 |
| 351 |
ANAEMIA |
2514 |
0.0132 |
| 352 |
ACUTE CORONARY SYNDROME |
108 |
0.0130 |
| 353 |
HYPERBILIRUBINAEMIA |
135 |
0.0130 |
| 354 |
FIBRIN D DIMER INCREASED |
46 |
0.0129 |
| 355 |
HYPERGLYCAEMIA |
464 |
0.0127 |
| 356 |
TUMOUR MARKER INCREASED |
61 |
0.0127 |
| 357 |
HYPERTHERMIA |
97 |
0.0127 |
| 358 |
FACIAL PARALYSIS |
108 |
0.0127 |
| 359 |
HYPERURICAEMIA |
52 |
0.0126 |
| 360 |
BRAIN OEDEMA |
159 |
0.0126 |
| 361 |
ACUTE RESPIRATORY FAILURE |
236 |
0.0123 |
| 362 |
FEEDING DISORDER |
248 |
0.0122 |
| 363 |
NEUTROPENIC SEPSIS |
87 |
0.0122 |
| 364 |
ELECTROLYTE IMBALANCE |
141 |
0.0121 |
| 365 |
DYSAESTHESIA |
37 |
0.0121 |
| 366 |
EOSINOPHILIC PNEUMONIA |
38 |
0.0120 |
| 367 |
CARDIOGENIC SHOCK |
173 |
0.0120 |
| 368 |
NECROSIS |
67 |
0.0120 |
| 369 |
UVEITIS |
163 |
0.0120 |
| 370 |
PANCREATIC DISORDER |
59 |
0.0120 |
| 371 |
ERYSIPELAS |
60 |
0.0119 |
| 372 |
PLATELET COUNT ABNORMAL |
72 |
0.0119 |
| 373 |
CARDIAC FAILURE |
956 |
0.0119 |
| 374 |
LUMBAR VERTEBRAL FRACTURE |
54 |
0.0118 |
| 375 |
OPTIC NEURITIS |
107 |
0.0118 |
| 376 |
RESPIRATORY FAILURE |
857 |
0.0117 |
| 377 |
LIVER FUNCTION TEST INCREASED |
252 |
0.0117 |
| 378 |
VASCULITIS |
136 |
0.0117 |
| 379 |
PURPURA |
103 |
0.0116 |
| 380 |
PYREXIA |
4018 |
0.0116 |
| 381 |
STAPHYLOCOCCAL BACTERAEMIA |
50 |
0.0115 |
| 382 |
EOSINOPHILIA |
201 |
0.0115 |
| 383 |
HEPATIC FAILURE |
343 |
0.0114 |
| 384 |
BONE LESION |
41 |
0.0114 |
| 385 |
FAILURE TO THRIVE |
59 |
0.0114 |
| 386 |
HEPATIC LESION |
49 |
0.0113 |
| 387 |
EMBOLISM |
94 |
0.0113 |
| 388 |
ALTERED STATE OF CONSCIOUSNESS |
245 |
0.0113 |
| 389 |
ENDOCARDITIS |
58 |
0.0113 |
| 390 |
BLOOD BILIRUBIN INCREASED |
305 |
0.0113 |
| 391 |
PERIPHERAL ISCHAEMIA |
46 |
0.0113 |
| 392 |
HYPOKALAEMIA |
519 |
0.0112 |
| 393 |
VENOUS THROMBOSIS |
44 |
0.0112 |
| 394 |
THROMBOTIC MICROANGIOPATHY |
109 |
0.0112 |
| 395 |
METASTASES TO LYMPH NODES |
75 |
0.0111 |
| 396 |
AORTIC DISSECTION |
46 |
0.0111 |
| 397 |
BLOOD PRESSURE ABNORMAL |
219 |
0.0110 |
| 398 |
PULMONARY TUBERCULOSIS |
47 |
0.0110 |
| 399 |
GRANULOMA |
38 |
0.0110 |
| 400 |
SUDDEN DEATH |
116 |
0.0110 |
| 401 |
LUNG DISORDER |
536 |
0.0109 |
| 402 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1265 |
0.0109 |
| 403 |
BLOOD CREATINE INCREASED |
48 |
0.0108 |
| 404 |
PATHOLOGICAL FRACTURE |
55 |
0.0108 |
| 405 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
38 |
0.0108 |
| 406 |
LYMPHADENOPATHY |
380 |
0.0107 |
| 407 |
HAEMOPTYSIS |
295 |
0.0106 |
| 408 |
RENAL FUNCTION TEST ABNORMAL |
49 |
0.0105 |
| 409 |
ORAL PAIN |
236 |
0.0105 |
| 410 |
BONE MARROW FAILURE |
213 |
0.0105 |
| 411 |
CORONAVIRUS INFECTION |
69 |
0.0104 |
| 412 |
HYPERTRIGLYCERIDAEMIA |
61 |
0.0104 |
| 413 |
LYMPHOEDEMA |
72 |
0.0104 |
| 414 |
APLASTIC ANAEMIA |
54 |
0.0103 |
| 415 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
182 |
0.0103 |
| 416 |
PYODERMA GANGRENOSUM |
37 |
0.0103 |
| 417 |
INFUSION SITE EXTRAVASATION |
64 |
0.0103 |
| 418 |
EOSINOPHIL COUNT INCREASED |
85 |
0.0102 |
| 419 |
WHITE BLOOD CELL COUNT ABNORMAL |
65 |
0.0102 |
| 420 |
GENERALISED OEDEMA |
126 |
0.0102 |
| 421 |
PANCREATITIS |
538 |
0.0102 |
| 422 |
LEFT VENTRICULAR DYSFUNCTION |
68 |
0.0101 |
| 423 |
SEPSIS |
1123 |
0.0101 |
| 424 |
METASTASES TO BONE |
165 |
0.0100 |
| 425 |
BLOOD SODIUM DECREASED |
189 |
0.0100 |
| 426 |
HEPATIC ENZYME INCREASED |
679 |
0.0100 |
| 427 |
IMMUNE SYSTEM DISORDER |
131 |
0.0099 |
| 428 |
NAIL DISCOLOURATION |
39 |
0.0099 |
| 429 |
SMALL INTESTINAL OBSTRUCTION |
122 |
0.0099 |
| 430 |
BLOOD CREATININE INCREASED |
647 |
0.0099 |
| 431 |
CUTANEOUS VASCULITIS |
36 |
0.0099 |
| 432 |
PULMONARY EMBOLISM |
935 |
0.0098 |
| 433 |
HEPATIC ENZYME ABNORMAL |
49 |
0.0098 |
| 434 |
CHEILITIS |
53 |
0.0098 |
| 435 |
ISCHAEMIA |
45 |
0.0098 |
| 436 |
PLEURISY |
58 |
0.0098 |
| 437 |
ENCEPHALOPATHY |
239 |
0.0097 |
| 438 |
HEPATIC ENCEPHALOPATHY |
90 |
0.0096 |
| 439 |
PERICARDITIS |
162 |
0.0096 |
| 440 |
RED CELL DISTRIBUTION WIDTH INCREASED |
40 |
0.0096 |
| 441 |
NEUROLOGICAL SYMPTOM |
55 |
0.0096 |
| 442 |
HYPOCALCAEMIA |
182 |
0.0096 |
| 443 |
MALNUTRITION |
107 |
0.0096 |
| 444 |
AZOTAEMIA |
38 |
0.0095 |
| 445 |
HYPOPHAGIA |
241 |
0.0094 |
| 446 |
HYPERKERATOSIS |
52 |
0.0094 |
| 447 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
148 |
0.0093 |
| 448 |
NEUROTOXICITY |
163 |
0.0093 |
| 449 |
METASTASES TO LIVER |
163 |
0.0093 |
| 450 |
INTESTINAL ISCHAEMIA |
51 |
0.0093 |
| 451 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1654 |
0.0092 |
| 452 |
DIARRHOEA |
5920 |
0.0092 |
| 453 |
CLOSTRIDIUM DIFFICILE COLITIS |
97 |
0.0091 |
| 454 |
SECOND PRIMARY MALIGNANCY |
76 |
0.0091 |
| 455 |
EMPHYSEMA |
92 |
0.0091 |
| 456 |
GINGIVITIS |
49 |
0.0091 |
| 457 |
HYPOXIA |
319 |
0.0090 |
| 458 |
LUNG INFILTRATION |
80 |
0.0090 |
| 459 |
APPETITE DISORDER |
60 |
0.0090 |
| 460 |
VASCULAR DEVICE INFECTION |
41 |
0.0090 |
| 461 |
HYPOVOLAEMIC SHOCK |
43 |
0.0090 |
| 462 |
SQUAMOUS CELL CARCINOMA OF SKIN |
54 |
0.0089 |
| 463 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
222 |
0.0089 |
| 464 |
CEREBRAL ISCHAEMIA |
46 |
0.0089 |
| 465 |
GASTRITIS |
235 |
0.0089 |
| 466 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
257 |
0.0089 |
| 467 |
RASH |
3883 |
0.0089 |
| 468 |
DISEASE PROGRESSION |
1053 |
0.0089 |
| 469 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
197 |
0.0089 |
| 470 |
RASH PRURITIC |
480 |
0.0088 |
| 471 |
ISCHAEMIC STROKE |
157 |
0.0088 |
| 472 |
COLITIS ISCHAEMIC |
59 |
0.0087 |
| 473 |
LIP OEDEMA |
37 |
0.0087 |
| 474 |
TONGUE DISCOMFORT |
37 |
0.0087 |
| 475 |
BLOOD PRESSURE DIASTOLIC INCREASED |
40 |
0.0087 |
| 476 |
PARONYCHIA |
38 |
0.0086 |
| 477 |
METASTASIS |
61 |
0.0085 |
| 478 |
DEHYDRATION |
1135 |
0.0085 |
| 479 |
GASTROINTESTINAL MOTILITY DISORDER |
45 |
0.0084 |
| 480 |
HICCUPS |
69 |
0.0084 |
| 481 |
TRANSFUSION |
88 |
0.0084 |
| 482 |
ABDOMINAL ABSCESS |
37 |
0.0084 |
| 483 |
MALIGNANT MELANOMA |
112 |
0.0084 |
| 484 |
ARTERIOSCLEROSIS CORONARY ARTERY |
55 |
0.0083 |
| 485 |
PULMONARY FIBROSIS |
159 |
0.0083 |
| 486 |
LYMPHOPENIA |
117 |
0.0083 |
| 487 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
64 |
0.0082 |
| 488 |
DIABETES MELLITUS |
623 |
0.0082 |
| 489 |
SHOCK HAEMORRHAGIC |
66 |
0.0081 |
| 490 |
STAPHYLOCOCCAL SEPSIS |
40 |
0.0081 |
| 491 |
GASTRIC ULCER |
153 |
0.0080 |
| 492 |
BLOOD PRESSURE INCREASED |
1216 |
0.0079 |
| 493 |
C-REACTIVE PROTEIN ABNORMAL |
51 |
0.0079 |
| 494 |
THERAPY NON-RESPONDER |
356 |
0.0079 |
| 495 |
ARTERIOSCLEROSIS |
74 |
0.0079 |
| 496 |
ORAL DISORDER |
57 |
0.0078 |
| 497 |
RENAL FAILURE |
1031 |
0.0078 |
| 498 |
DERMATITIS ACNEIFORM |
47 |
0.0077 |
| 499 |
HAEMATURIA |
264 |
0.0077 |
| 500 |
DYSPHAGIA |
731 |
0.0077 |
| 501 |
ACUTE MYELOID LEUKAEMIA |
120 |
0.0077 |
| 502 |
PULMONARY ALVEOLAR HAEMORRHAGE |
43 |
0.0077 |
| 503 |
PANCREATITIS ACUTE |
172 |
0.0076 |
| 504 |
FISTULA |
86 |
0.0076 |
| 505 |
ASTHENIA |
2865 |
0.0076 |
| 506 |
PIGMENTATION DISORDER |
47 |
0.0076 |
| 507 |
ORAL CANDIDIASIS |
100 |
0.0076 |
| 508 |
SPINAL COMPRESSION FRACTURE |
62 |
0.0075 |
| 509 |
BRONCHOPULMONARY ASPERGILLOSIS |
58 |
0.0075 |
| 510 |
FLANK PAIN |
70 |
0.0075 |
| 511 |
BLOOD UREA INCREASED |
125 |
0.0075 |
| 512 |
LARYNGEAL OEDEMA |
46 |
0.0075 |
| 513 |
DRY MOUTH |
605 |
0.0074 |
| 514 |
HYPERKALAEMIA |
260 |
0.0074 |
| 515 |
WEIGHT FLUCTUATION |
77 |
0.0074 |
| 516 |
ILL-DEFINED DISORDER |
445 |
0.0073 |
| 517 |
DYSPNOEA EXERTIONAL |
275 |
0.0073 |
| 518 |
LIVER INJURY |
177 |
0.0072 |
| 519 |
DELIRIUM |
249 |
0.0072 |
| 520 |
BLOOD PRESSURE FLUCTUATION |
172 |
0.0072 |
| 521 |
BLISTER |
399 |
0.0071 |
| 522 |
COMPRESSION FRACTURE |
38 |
0.0071 |
| 523 |
PNEUMONIA |
2292 |
0.0071 |
| 524 |
BACTERAEMIA |
84 |
0.0071 |
| 525 |
ACUTE MYOCARDIAL INFARCTION |
208 |
0.0070 |
| 526 |
BLOOD CALCIUM DECREASED |
79 |
0.0070 |
| 527 |
DEVICE RELATED INFECTION |
108 |
0.0070 |
| 528 |
DEATH |
6043 |
0.0070 |
| 529 |
OEDEMA |
380 |
0.0070 |
| 530 |
PERITONITIS |
145 |
0.0070 |
| 531 |
GENERAL PHYSICAL CONDITION ABNORMAL |
47 |
0.0069 |
| 532 |
CANDIDA INFECTION |
117 |
0.0069 |
| 533 |
HYPERTENSIVE CRISIS |
77 |
0.0069 |
| 534 |
GASTROINTESTINAL INFLAMMATION |
54 |
0.0069 |
| 535 |
AGEUSIA |
171 |
0.0068 |
| 536 |
DRUG RESISTANCE |
176 |
0.0068 |
| 537 |
UROSEPSIS |
63 |
0.0068 |
| 538 |
DIPLOPIA |
177 |
0.0068 |
| 539 |
CONSTIPATION |
1477 |
0.0068 |
| 540 |
ASPIRATION |
74 |
0.0067 |
| 541 |
INTESTINAL OBSTRUCTION |
254 |
0.0067 |
| 542 |
WEIGHT DECREASED |
1881 |
0.0067 |
| 543 |
FAECES SOFT |
49 |
0.0067 |
| 544 |
FATIGUE |
5236 |
0.0067 |
| 545 |
GROIN PAIN |
59 |
0.0067 |
| 546 |
LEUKOCYTOSIS |
121 |
0.0067 |
| 547 |
SUBARACHNOID HAEMORRHAGE |
68 |
0.0067 |
| 548 |
SHOCK |
153 |
0.0066 |
| 549 |
NEUTROPHIL COUNT INCREASED |
68 |
0.0066 |
| 550 |
RENAL DISORDER |
309 |
0.0066 |
| 551 |
WHITE BLOOD CELL COUNT DECREASED |
710 |
0.0065 |
| 552 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
54 |
0.0065 |
| 553 |
PULMONARY HAEMORRHAGE |
51 |
0.0065 |
| 554 |
RASH PAPULAR |
146 |
0.0065 |
| 555 |
CEREBRAL HAEMORRHAGE |
232 |
0.0065 |
| 556 |
VENTRICULAR TACHYCARDIA |
107 |
0.0065 |
| 557 |
JAUNDICE |
174 |
0.0065 |
| 558 |
ABNORMAL LOSS OF WEIGHT |
44 |
0.0064 |
| 559 |
LYMPHOCYTE COUNT DECREASED |
114 |
0.0064 |
| 560 |
GAIT INABILITY |
215 |
0.0064 |
| 561 |
DECREASED ACTIVITY |
69 |
0.0064 |
| 562 |
APHONIA |
89 |
0.0064 |
| 563 |
SPINAL OSTEOARTHRITIS |
56 |
0.0064 |
| 564 |
ODYNOPHAGIA |
38 |
0.0064 |
| 565 |
PRODUCT PRESCRIBING ISSUE |
138 |
0.0063 |
| 566 |
RESPIRATORY DISTRESS |
174 |
0.0063 |
| 567 |
EATING DISORDER |
133 |
0.0062 |
| 568 |
MYALGIA |
1061 |
0.0062 |
| 569 |
HAEMOLYSIS |
48 |
0.0062 |
| 570 |
ATRIOVENTRICULAR BLOCK |
48 |
0.0062 |
| 571 |
DIARRHOEA HAEMORRHAGIC |
58 |
0.0062 |
| 572 |
RETINAL DETACHMENT |
57 |
0.0062 |
| 573 |
ADVERSE REACTION |
82 |
0.0062 |
| 574 |
FACE OEDEMA |
104 |
0.0062 |
| 575 |
ANAPHYLACTIC SHOCK |
159 |
0.0062 |
| 576 |
INABILITY TO AFFORD MEDICATION |
61 |
0.0061 |
| 577 |
ATRIAL FLUTTER |
49 |
0.0061 |
| 578 |
COVID-19 PNEUMONIA |
72 |
0.0061 |
| 579 |
BRONCHIECTASIS |
41 |
0.0061 |
| 580 |
SKIN ULCER |
157 |
0.0061 |
| 581 |
INFUSION RELATED REACTION |
402 |
0.0061 |
| 582 |
NASAL DRYNESS |
38 |
0.0061 |
| 583 |
MUSCULAR WEAKNESS |
688 |
0.0060 |
| 584 |
DECUBITUS ULCER |
49 |
0.0060 |
| 585 |
BRAIN FOG |
94 |
0.0060 |
| 586 |
MOUTH ULCERATION |
125 |
0.0059 |
| 587 |
RENAL CYST |
47 |
0.0059 |
| 588 |
ACIDOSIS |
45 |
0.0059 |
| 589 |
THIRST |
105 |
0.0059 |
| 590 |
MOUTH HAEMORRHAGE |
43 |
0.0059 |
| 591 |
MELAENA |
129 |
0.0059 |
| 592 |
SUPRAVENTRICULAR TACHYCARDIA |
56 |
0.0058 |
| 593 |
NEOPLASM |
67 |
0.0058 |
| 594 |
EPISTAXIS |
435 |
0.0058 |
| 595 |
CYTOMEGALOVIRUS INFECTION |
96 |
0.0058 |
| 596 |
PROCTALGIA |
37 |
0.0057 |
| 597 |
TRANSPLANT REJECTION |
46 |
0.0057 |
| 598 |
ATRIAL FIBRILLATION |
558 |
0.0057 |
| 599 |
ATAXIA |
68 |
0.0057 |
| 600 |
PSEUDOMONAS INFECTION |
49 |
0.0057 |
| 601 |
DIABETES MELLITUS INADEQUATE CONTROL |
101 |
0.0057 |
| 602 |
SCAB |
65 |
0.0057 |
| 603 |
ARTHRITIS |
447 |
0.0057 |
| 604 |
PAPULE |
40 |
0.0057 |
| 605 |
GINGIVAL PAIN |
45 |
0.0056 |
| 606 |
GASTROENTERITIS |
82 |
0.0056 |
| 607 |
MUSCLE ATROPHY |
71 |
0.0056 |
| 608 |
MALAISE |
2455 |
0.0056 |
| 609 |
OFF LABEL USE |
4866 |
0.0056 |
| 610 |
DEEP VEIN THROMBOSIS |
360 |
0.0055 |
| 611 |
RED BLOOD CELL COUNT DECREASED |
157 |
0.0055 |
| 612 |
VENTRICULAR EXTRASYSTOLES |
57 |
0.0055 |
| 613 |
BLOOD TEST ABNORMAL |
77 |
0.0055 |
| 614 |
INFLAMMATION |
280 |
0.0054 |
| 615 |
SINUS TACHYCARDIA |
77 |
0.0054 |
| 616 |
HYPOPHOSPHATAEMIA |
40 |
0.0054 |
| 617 |
OEDEMA PERIPHERAL |
659 |
0.0054 |
| 618 |
NAIL DISORDER |
47 |
0.0054 |
| 619 |
PULMONARY OEDEMA |
240 |
0.0054 |
| 620 |
RHABDOMYOLYSIS |
223 |
0.0053 |
| 621 |
FRUSTRATION TOLERANCE DECREASED |
43 |
0.0053 |
| 622 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
154 |
0.0053 |
| 623 |
APPENDICITIS |
49 |
0.0052 |
| 624 |
BLOOD DISORDER |
42 |
0.0052 |
| 625 |
MOTOR DYSFUNCTION |
53 |
0.0052 |
| 626 |
SKIN LESION |
142 |
0.0052 |
| 627 |
COLITIS ULCERATIVE |
231 |
0.0052 |
| 628 |
WHITE BLOOD CELL COUNT INCREASED |
198 |
0.0052 |
| 629 |
URINARY TRACT INFECTION |
877 |
0.0051 |
| 630 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
38 |
0.0051 |
| 631 |
MOVEMENT DISORDER |
165 |
0.0051 |
| 632 |
BLOOD CALCIUM INCREASED |
45 |
0.0051 |
| 633 |
POLYURIA |
42 |
0.0051 |
| 634 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
86 |
0.0051 |
| 635 |
BLOOD POTASSIUM DECREASED |
153 |
0.0051 |
| 636 |
MUSCLE DISORDER |
41 |
0.0051 |
| 637 |
ABDOMINAL PAIN |
1177 |
0.0051 |
| 638 |
NODULE |
66 |
0.0051 |
| 639 |
ACUTE HEPATIC FAILURE |
69 |
0.0050 |
| 640 |
REBOUND EFFECT |
57 |
0.0050 |
| 641 |
PHOTOSENSITIVITY REACTION |
83 |
0.0050 |
| 642 |
BLOOD PRESSURE DECREASED |
331 |
0.0050 |
| 643 |
HEMIPARESIS |
84 |
0.0050 |
| 644 |
VOMITING |
2324 |
0.0049 |
| 645 |
HYPOTENSION |
988 |
0.0049 |
| 646 |
CLOSTRIDIUM DIFFICILE INFECTION |
107 |
0.0049 |
| 647 |
EPILEPSY |
149 |
0.0049 |
| 648 |
BLOOD PRESSURE SYSTOLIC INCREASED |
95 |
0.0049 |
| 649 |
CEREBRAL DISORDER |
36 |
0.0049 |
| 650 |
CONJUNCTIVITIS |
90 |
0.0048 |
| 651 |
OXYGEN SATURATION DECREASED |
272 |
0.0048 |
| 652 |
URINARY RETENTION |
160 |
0.0048 |
| 653 |
MUSCULOSKELETAL CHEST PAIN |
74 |
0.0048 |
| 654 |
SQUAMOUS CELL CARCINOMA |
45 |
0.0048 |
| 655 |
HEPATIC STEATOSIS |
89 |
0.0048 |
| 656 |
INSURANCE ISSUE |
73 |
0.0048 |
| 657 |
RESPIRATORY TRACT INFECTION |
124 |
0.0048 |
| 658 |
PRURITUS |
1825 |
0.0047 |
| 659 |
ARTHRALGIA |
1973 |
0.0047 |
| 660 |
NERVOUS SYSTEM DISORDER |
148 |
0.0047 |
| 661 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
260 |
0.0047 |
| 662 |
DYSURIA |
174 |
0.0047 |
| 663 |
CELLULITIS |
237 |
0.0047 |
| 664 |
CARDIO-RESPIRATORY ARREST |
196 |
0.0047 |
| 665 |
ASPHYXIA |
38 |
0.0047 |
| 666 |
RASH ERYTHEMATOUS |
222 |
0.0046 |
| 667 |
NAUSEA |
3672 |
0.0046 |
| 668 |
ECZEMA |
242 |
0.0046 |
| 669 |
GINGIVAL BLEEDING |
63 |
0.0046 |
| 670 |
LIVER FUNCTION TEST ABNORMAL |
134 |
0.0046 |
| 671 |
CHILLS |
538 |
0.0046 |
| 672 |
GLOSSODYNIA |
102 |
0.0046 |
| 673 |
GASTROINTESTINAL DISORDER |
408 |
0.0045 |
| 674 |
BONE PAIN |
266 |
0.0045 |
| 675 |
HAEMATOCRIT DECREASED |
90 |
0.0045 |
| 676 |
ORAL DISCOMFORT |
63 |
0.0045 |
| 677 |
CIRCULATORY COLLAPSE |
77 |
0.0045 |
| 678 |
ABNORMAL FAECES |
37 |
0.0045 |
| 679 |
IMPAIRED HEALING |
148 |
0.0045 |
| 680 |
MYOCARDIAL ISCHAEMIA |
51 |
0.0045 |
| 681 |
SKIN INFECTION |
50 |
0.0045 |
| 682 |
INFECTION |
645 |
0.0045 |
| 683 |
FEELING COLD |
124 |
0.0044 |
| 684 |
HAEMOGLOBIN DECREASED |
455 |
0.0044 |
| 685 |
NEPHROPATHY |
41 |
0.0044 |
| 686 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
95 |
0.0044 |
| 687 |
METABOLIC ACIDOSIS |
140 |
0.0044 |
| 688 |
BLOOD POTASSIUM INCREASED |
71 |
0.0044 |
| 689 |
DERMATITIS ALLERGIC |
55 |
0.0044 |
| 690 |
IMMUNOSUPPRESSION |
38 |
0.0043 |
| 691 |
BLOOD GLUCOSE ABNORMAL |
79 |
0.0043 |
| 692 |
DYSPNOEA |
2418 |
0.0043 |
| 693 |
PARALYSIS |
61 |
0.0043 |
| 694 |
NEURALGIA |
103 |
0.0042 |
| 695 |
BACTERIAL INFECTION |
79 |
0.0042 |
| 696 |
LUPUS-LIKE SYNDROME |
38 |
0.0042 |
| 697 |
MYELODYSPLASTIC SYNDROME |
60 |
0.0041 |
| 698 |
COUGH |
1156 |
0.0041 |
| 699 |
OSTEONECROSIS OF JAW |
102 |
0.0041 |
| 700 |
PETECHIAE |
43 |
0.0041 |
| 701 |
DYSSTASIA |
120 |
0.0041 |
| 702 |
ARRHYTHMIA |
192 |
0.0041 |
| 703 |
DYSARTHRIA |
152 |
0.0040 |
| 704 |
CARDIAC ARREST |
333 |
0.0040 |
| 705 |
BRAIN NEOPLASM |
37 |
0.0040 |
| 706 |
RASH MACULAR |
140 |
0.0040 |
| 707 |
HERPES ZOSTER |
230 |
0.0040 |
| 708 |
GASTRIC HAEMORRHAGE |
46 |
0.0040 |
| 709 |
HEPATIC CIRRHOSIS |
75 |
0.0040 |
| 710 |
COGNITIVE DISORDER |
186 |
0.0040 |
| 711 |
PRODUCTIVE COUGH |
189 |
0.0040 |
| 712 |
HYPOTHERMIA |
40 |
0.0039 |
| 713 |
TYPE 2 DIABETES MELLITUS |
133 |
0.0039 |
| 714 |
CYSTITIS |
125 |
0.0039 |
| 715 |
APHASIA |
118 |
0.0039 |
| 716 |
VITREOUS FLOATERS |
38 |
0.0039 |
| 717 |
MENTAL STATUS CHANGES |
107 |
0.0038 |
| 718 |
DRY EYE |
192 |
0.0038 |
| 719 |
DYSGEUSIA |
285 |
0.0038 |
| 720 |
SEIZURE |
443 |
0.0038 |
| 721 |
PLATELET COUNT INCREASED |
50 |
0.0038 |
| 722 |
HAEMATEMESIS |
96 |
0.0038 |
| 723 |
ERYTHEMA |
778 |
0.0038 |
| 724 |
POOR VENOUS ACCESS |
39 |
0.0038 |
| 725 |
SPINAL PAIN |
44 |
0.0038 |
| 726 |
NO ADVERSE EVENT |
677 |
0.0037 |
| 727 |
SURGERY |
218 |
0.0037 |
| 728 |
GASTROINTESTINAL HAEMORRHAGE |
310 |
0.0037 |
| 729 |
LABORATORY TEST ABNORMAL |
109 |
0.0037 |
| 730 |
INCONTINENCE |
39 |
0.0037 |
| 731 |
DEMENTIA |
103 |
0.0037 |
| 732 |
POOR QUALITY SLEEP |
79 |
0.0037 |
| 733 |
TOXICITY TO VARIOUS AGENTS |
618 |
0.0037 |
| 734 |
HEPATOMEGALY |
36 |
0.0037 |
| 735 |
HAEMATOCHEZIA |
202 |
0.0037 |
| 736 |
TACHYCARDIA |
325 |
0.0037 |
| 737 |
THROMBOSIS |
294 |
0.0037 |
| 738 |
CARPAL TUNNEL SYNDROME |
51 |
0.0036 |
| 739 |
SARS-COV-2 TEST POSITIVE |
48 |
0.0036 |
| 740 |
SKIN EXFOLIATION |
306 |
0.0036 |
| 741 |
LYMPHOMA |
56 |
0.0036 |
| 742 |
RHEUMATOID ARTHRITIS |
406 |
0.0036 |
| 743 |
ANAPHYLACTIC REACTION |
197 |
0.0036 |
| 744 |
HAEMORRHAGE INTRACRANIAL |
53 |
0.0035 |
| 745 |
CONFUSIONAL STATE |
569 |
0.0035 |
| 746 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
139 |
0.0035 |
| 747 |
DRUG INTOLERANCE |
339 |
0.0035 |
| 748 |
BACK PAIN |
811 |
0.0035 |
| 749 |
DIVERTICULITIS |
96 |
0.0035 |
| 750 |
RECTAL HAEMORRHAGE |
147 |
0.0034 |
| 751 |
GLOMERULAR FILTRATION RATE DECREASED |
42 |
0.0034 |
| 752 |
TRANSIENT ISCHAEMIC ATTACK |
115 |
0.0034 |
| 753 |
ALOPECIA |
667 |
0.0034 |
| 754 |
BLOOD URINE PRESENT |
64 |
0.0034 |
| 755 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
86 |
0.0033 |
| 756 |
VENTRICULAR FIBRILLATION |
37 |
0.0033 |
| 757 |
FULL BLOOD COUNT DECREASED |
67 |
0.0033 |
| 758 |
IMMUNODEFICIENCY |
49 |
0.0033 |
| 759 |
LACRIMATION INCREASED |
99 |
0.0033 |
| 760 |
STATUS EPILEPTICUS |
37 |
0.0033 |
| 761 |
CENTRAL NERVOUS SYSTEM LESION |
45 |
0.0033 |
| 762 |
MUSCULOSKELETAL PAIN |
170 |
0.0032 |
| 763 |
COAGULOPATHY |
54 |
0.0032 |
| 764 |
PERIPHERAL SWELLING |
499 |
0.0032 |
| 765 |
HAEMORRHOIDS |
63 |
0.0032 |
| 766 |
HYPOGLYCAEMIA |
156 |
0.0032 |
| 767 |
OSTEOMYELITIS |
58 |
0.0032 |
| 768 |
SPEECH DISORDER |
166 |
0.0032 |
| 769 |
LUNG INFECTION |
49 |
0.0032 |
| 770 |
MASS |
44 |
0.0031 |
| 771 |
FAECES DISCOLOURED |
68 |
0.0031 |
| 772 |
COVID-19 |
549 |
0.0031 |
| 773 |
DRY SKIN |
416 |
0.0031 |
| 774 |
PULMONARY CONGESTION |
41 |
0.0031 |
| 775 |
HYPOAESTHESIA |
465 |
0.0031 |
| 776 |
ADVERSE DRUG REACTION |
278 |
0.0031 |
| 777 |
CARDIOMEGALY |
38 |
0.0031 |
| 778 |
THERAPEUTIC RESPONSE UNEXPECTED |
138 |
0.0031 |
| 779 |
SUBDURAL HAEMATOMA |
44 |
0.0031 |
| 780 |
ANGINA PECTORIS |
88 |
0.0031 |
| 781 |
QUALITY OF LIFE DECREASED |
41 |
0.0031 |
| 782 |
PALLOR |
83 |
0.0030 |
| 783 |
ORTHOSTATIC HYPOTENSION |
53 |
0.0030 |
| 784 |
LUNG NEOPLASM MALIGNANT |
125 |
0.0030 |
| 785 |
BODY TEMPERATURE INCREASED |
62 |
0.0030 |
| 786 |
FRACTURE |
57 |
0.0030 |
| 787 |
ABDOMINAL PAIN LOWER |
76 |
0.0030 |
| 788 |
DEAFNESS |
78 |
0.0030 |
| 789 |
URINARY INCONTINENCE |
88 |
0.0030 |
| 790 |
HYPERSOMNIA |
85 |
0.0030 |
| 791 |
GENERALISED TONIC-CLONIC SEIZURE |
49 |
0.0030 |
| 792 |
MUSCULOSKELETAL DISORDER |
56 |
0.0029 |
| 793 |
TACHYPNOEA |
40 |
0.0029 |
| 794 |
LETHARGY |
169 |
0.0029 |
| 795 |
CHEST PAIN |
543 |
0.0029 |
| 796 |
CHROMATURIA |
66 |
0.0029 |
| 797 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
152 |
0.0029 |
| 798 |
COLON CANCER |
43 |
0.0029 |
| 799 |
ABSCESS |
46 |
0.0029 |
| 800 |
STAPHYLOCOCCAL INFECTION |
95 |
0.0029 |
| 801 |
ELECTROCARDIOGRAM QT PROLONGED |
103 |
0.0029 |
| 802 |
GAIT DISTURBANCE |
541 |
0.0028 |
| 803 |
JOINT STIFFNESS |
74 |
0.0028 |
| 804 |
GOUT |
50 |
0.0028 |
| 805 |
RASH GENERALISED |
72 |
0.0028 |
| 806 |
ULCER |
44 |
0.0028 |
| 807 |
SKIN DISCOLOURATION |
126 |
0.0027 |
| 808 |
BEDRIDDEN |
36 |
0.0027 |
| 809 |
POLLAKIURIA |
114 |
0.0027 |
| 810 |
HAEMORRHAGE |
285 |
0.0027 |
| 811 |
CHOLELITHIASIS |
89 |
0.0027 |
| 812 |
UNRESPONSIVE TO STIMULI |
70 |
0.0027 |
| 813 |
PAIN IN EXTREMITY |
793 |
0.0027 |
| 814 |
NECK PAIN |
150 |
0.0027 |
| 815 |
BALANCE DISORDER |
231 |
0.0027 |
| 816 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
190 |
0.0027 |
| 817 |
THERAPY CESSATION |
136 |
0.0026 |
| 818 |
PRESYNCOPE |
64 |
0.0026 |
| 819 |
FUNGAL INFECTION |
87 |
0.0026 |
| 820 |
RESPIRATORY DISORDER |
78 |
0.0026 |
| 821 |
CYANOSIS |
41 |
0.0026 |
| 822 |
SPINAL FRACTURE |
52 |
0.0026 |
| 823 |
DYSPEPSIA |
254 |
0.0026 |
| 824 |
CEREBROVASCULAR ACCIDENT |
436 |
0.0026 |
| 825 |
ABDOMINAL PAIN UPPER |
528 |
0.0026 |
| 826 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
123 |
0.0026 |
| 827 |
DISORIENTATION |
100 |
0.0025 |
| 828 |
OROPHARYNGEAL PAIN |
228 |
0.0025 |
| 829 |
TREATMENT FAILURE |
204 |
0.0025 |
| 830 |
PSORIASIS |
321 |
0.0025 |
| 831 |
PARAESTHESIA |
386 |
0.0025 |
| 832 |
HEART RATE DECREASED |
86 |
0.0024 |
| 833 |
CORONARY ARTERY DISEASE |
74 |
0.0024 |
| 834 |
TOOTHACHE |
44 |
0.0024 |
| 835 |
SYNCOPE |
242 |
0.0024 |
| 836 |
NEOPLASM MALIGNANT |
161 |
0.0024 |
| 837 |
CONDITION AGGRAVATED |
731 |
0.0024 |
| 838 |
NIGHT SWEATS |
77 |
0.0024 |
| 839 |
CHEST DISCOMFORT |
241 |
0.0024 |
| 840 |
ILLNESS |
241 |
0.0023 |
| 841 |
SOMNOLENCE |
471 |
0.0023 |
| 842 |
BLINDNESS |
95 |
0.0023 |
| 843 |
ORAL HERPES |
45 |
0.0023 |
| 844 |
FEAR |
62 |
0.0023 |
| 845 |
TOOTH DISORDER |
51 |
0.0023 |
| 846 |
PAIN |
1389 |
0.0023 |
| 847 |
VISUAL IMPAIRMENT |
279 |
0.0022 |
| 848 |
POST PROCEDURAL COMPLICATION |
43 |
0.0022 |
| 849 |
DEPRESSED MOOD |
118 |
0.0022 |
| 850 |
FLATULENCE |
126 |
0.0022 |
| 851 |
MUSCULOSKELETAL DISCOMFORT |
38 |
0.0022 |
| 852 |
HEADACHE |
1381 |
0.0022 |
| 853 |
EYE DISORDER |
72 |
0.0022 |
| 854 |
MYOCARDIAL INFARCTION |
382 |
0.0022 |
| 855 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
37 |
0.0022 |
| 856 |
BLOOD TRIGLYCERIDES INCREASED |
38 |
0.0021 |
| 857 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
76 |
0.0021 |
| 858 |
SLEEP DISORDER |
151 |
0.0021 |
| 859 |
PHOTOPHOBIA |
40 |
0.0021 |
| 860 |
PAIN OF SKIN |
57 |
0.0021 |
| 861 |
LOSS OF CONSCIOUSNESS |
271 |
0.0021 |
| 862 |
FREQUENT BOWEL MOVEMENTS |
57 |
0.0021 |
| 863 |
VISUAL ACUITY REDUCED |
69 |
0.0021 |
| 864 |
GALLBLADDER DISORDER |
37 |
0.0021 |
| 865 |
RETCHING |
44 |
0.0021 |
| 866 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
52 |
0.0021 |
| 867 |
BRADYCARDIA |
109 |
0.0021 |
| 868 |
INCREASED APPETITE |
39 |
0.0020 |
| 869 |
ABDOMINAL DISTENSION |
213 |
0.0020 |
| 870 |
HOSPITALISATION |
313 |
0.0020 |
| 871 |
DRUG INEFFECTIVE |
2660 |
0.0020 |
| 872 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
68 |
0.0020 |
| 873 |
HEART RATE INCREASED |
199 |
0.0020 |
| 874 |
URTICARIA |
336 |
0.0020 |
| 875 |
WOUND |
56 |
0.0020 |
| 876 |
VISION BLURRED |
275 |
0.0020 |
| 877 |
RIB FRACTURE |
41 |
0.0020 |
| 878 |
KIDNEY INFECTION |
39 |
0.0020 |
| 879 |
RHINORRHOEA |
128 |
0.0020 |
| 880 |
DRUG INTERACTION |
313 |
0.0020 |
| 881 |
PULMONARY HYPERTENSION |
41 |
0.0020 |
| 882 |
CHRONIC KIDNEY DISEASE |
149 |
0.0020 |
| 883 |
CARDIAC DISORDER |
183 |
0.0020 |
| 884 |
RENAL INJURY |
58 |
0.0020 |
| 885 |
UNDERDOSE |
141 |
0.0019 |
| 886 |
LIP SWELLING |
64 |
0.0019 |
| 887 |
ANGIOEDEMA |
85 |
0.0019 |
| 888 |
ABDOMINAL DISCOMFORT |
320 |
0.0019 |
| 889 |
MOBILITY DECREASED |
137 |
0.0019 |
| 890 |
EAR PAIN |
37 |
0.0019 |
| 891 |
BLOOD GLUCOSE INCREASED |
355 |
0.0019 |
| 892 |
LIMB INJURY |
51 |
0.0019 |
| 893 |
LIMB DISCOMFORT |
58 |
0.0019 |
| 894 |
SWOLLEN TONGUE |
58 |
0.0019 |
| 895 |
VAGINAL HAEMORRHAGE |
80 |
0.0018 |
| 896 |
GASTROOESOPHAGEAL REFLUX DISEASE |
148 |
0.0018 |
| 897 |
LOWER RESPIRATORY TRACT INFECTION |
83 |
0.0018 |
| 898 |
CARDIAC FAILURE CONGESTIVE |
146 |
0.0018 |
| 899 |
CARDIOVASCULAR DISORDER |
46 |
0.0018 |
| 900 |
DIZZINESS |
899 |
0.0018 |
| 901 |
PRODUCT AVAILABILITY ISSUE |
41 |
0.0018 |
| 902 |
PRODUCT DOSE OMISSION ISSUE |
524 |
0.0018 |
| 903 |
JOINT SWELLING |
214 |
0.0018 |
| 904 |
VERTIGO |
108 |
0.0018 |
| 905 |
SWELLING |
165 |
0.0018 |
| 906 |
PSORIATIC ARTHROPATHY |
71 |
0.0017 |
| 907 |
TREMOR |
289 |
0.0017 |
| 908 |
MEMORY IMPAIRMENT |
239 |
0.0017 |
| 909 |
SWELLING FACE |
113 |
0.0017 |
| 910 |
FALL |
571 |
0.0017 |
| 911 |
VIRAL INFECTION |
57 |
0.0017 |
| 912 |
HOT FLUSH |
129 |
0.0017 |
| 913 |
FEELING ABNORMAL |
409 |
0.0017 |
| 914 |
INCORRECT DOSE ADMINISTERED |
389 |
0.0017 |
| 915 |
MENTAL IMPAIRMENT |
41 |
0.0017 |
| 916 |
MENTAL DISORDER |
73 |
0.0017 |
| 917 |
DISTURBANCE IN ATTENTION |
90 |
0.0017 |
| 918 |
AMNESIA |
108 |
0.0017 |
| 919 |
HYPERSENSITIVITY |
308 |
0.0017 |
| 920 |
COMA |
79 |
0.0017 |
| 921 |
INSOMNIA |
441 |
0.0017 |
| 922 |
INFLUENZA LIKE ILLNESS |
136 |
0.0017 |
| 923 |
DISEASE RECURRENCE |
78 |
0.0016 |
| 924 |
PALPITATIONS |
192 |
0.0016 |
| 925 |
WEIGHT INCREASED |
365 |
0.0016 |
| 926 |
PAIN IN JAW |
46 |
0.0016 |
| 927 |
FLUSHING |
163 |
0.0016 |
| 928 |
MUSCULOSKELETAL STIFFNESS |
140 |
0.0016 |
| 929 |
PRODUCT PRESCRIBING ERROR |
38 |
0.0016 |
| 930 |
TINNITUS |
73 |
0.0016 |
| 931 |
LOCALISED INFECTION |
38 |
0.0016 |
| 932 |
UPPER RESPIRATORY TRACT INFECTION |
72 |
0.0016 |
| 933 |
MUSCLE SPASMS |
285 |
0.0016 |
| 934 |
CATARACT |
90 |
0.0015 |
| 935 |
OSTEOARTHRITIS |
64 |
0.0015 |
| 936 |
OSTEOPOROSIS |
61 |
0.0015 |
| 937 |
HAEMATOMA |
38 |
0.0015 |
| 938 |
ARTHROPATHY |
81 |
0.0015 |
| 939 |
RESTLESSNESS |
53 |
0.0014 |
| 940 |
PROCEDURAL PAIN |
40 |
0.0014 |
| 941 |
HYPOACUSIS |
61 |
0.0014 |
| 942 |
INFLUENZA |
156 |
0.0014 |
| 943 |
HEAD INJURY |
44 |
0.0014 |
| 944 |
ANGER |
47 |
0.0014 |
| 945 |
FEMUR FRACTURE |
43 |
0.0014 |
| 946 |
HYPERHIDROSIS |
178 |
0.0014 |
| 947 |
PRODUCT DOSE OMISSION |
90 |
0.0014 |
| 948 |
NASAL CONGESTION |
81 |
0.0014 |
| 949 |
WHEEZING |
81 |
0.0014 |
| 950 |
DISCOMFORT |
83 |
0.0014 |
| 951 |
GASTRIC DISORDER |
46 |
0.0013 |
| 952 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
92 |
0.0013 |
| 953 |
BLOOD GLUCOSE DECREASED |
62 |
0.0013 |
| 954 |
ANXIETY |
364 |
0.0013 |
| 955 |
FEELING HOT |
77 |
0.0013 |
| 956 |
EYE PAIN |
69 |
0.0012 |
| 957 |
OCULAR HYPERAEMIA |
58 |
0.0012 |
| 958 |
HALLUCINATION |
91 |
0.0012 |
| 959 |
FLUID RETENTION |
61 |
0.0012 |
| 960 |
INTENTIONAL PRODUCT USE ISSUE |
105 |
0.0012 |
| 961 |
OSTEONECROSIS |
39 |
0.0012 |
| 962 |
HIP FRACTURE |
38 |
0.0012 |
| 963 |
THROAT IRRITATION |
53 |
0.0012 |
| 964 |
THERAPEUTIC RESPONSE DECREASED |
69 |
0.0011 |
| 965 |
SKIN IRRITATION |
52 |
0.0011 |
| 966 |
BURNING SENSATION |
79 |
0.0011 |
| 967 |
AGITATION |
82 |
0.0011 |
| 968 |
NEPHROLITHIASIS |
51 |
0.0011 |
| 969 |
EYE SWELLING |
41 |
0.0011 |
| 970 |
THERAPY INTERRUPTED |
78 |
0.0011 |
| 971 |
CONTUSION |
105 |
0.0011 |
| 972 |
SINUSITIS |
110 |
0.0011 |
| 973 |
PLASMA CELL MYELOMA |
41 |
0.0010 |
| 974 |
DEPRESSION |
233 |
0.0010 |
| 975 |
NASOPHARYNGITIS |
187 |
0.0010 |
| 976 |
BRONCHITIS |
74 |
0.0010 |
| 977 |
BLOOD CHOLESTEROL INCREASED |
44 |
0.0009 |
| 978 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
39 |
0.0009 |
| 979 |
TREATMENT NONCOMPLIANCE |
46 |
0.0008 |
| 980 |
ACNE |
60 |
0.0008 |
| 981 |
SKIN BURNING SENSATION |
55 |
0.0008 |
| 982 |
NERVOUSNESS |
40 |
0.0008 |
| 983 |
ASTHMA |
86 |
0.0008 |
| 984 |
MIGRAINE |
70 |
0.0007 |
| 985 |
IRRITABILITY |
43 |
0.0007 |
| 986 |
UNEVALUABLE EVENT |
46 |
0.0006 |
| 987 |
DRUG DOSE OMISSION |
97 |
0.0006 |
| 988 |
MATERNAL EXPOSURE DURING PREGNANCY |
43 |
0.0005 |
| 989 |
INTENTIONAL PRODUCT MISUSE |
42 |
0.0005 |
| 990 |
BREAST CANCER |
37 |
0.0004 |
| 991 |
ACCIDENTAL EXPOSURE TO PRODUCT |
39 |
0.0004 |
| 992 |
OVERDOSE |
81 |
0.0004 |
| 993 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
61 |
0.0003 |